Navigation Links
Genaera Liquidating Trust To Sell Remaining Proprietary Assets
Date:1/11/2010

SOUTHAMPTON, Pa., Jan. 11 /PRNewswire/ -- Argyce LLC, the trustee of the Genaera Liquidating Trust (the "Trust"), http://www.genaera.com, will divest the remaining drug development program assets of Genaera Corporation on an "as-is" basis. The Trust is soliciting bids to be received no later than February 12, 2010 for the assets, which may be purchased separately or in combination. Any person interested in purchasing the assets or learning more about the bidding process should contact the trustee's CEO, John Skolas.

The assets to be sold include the following:

  • IL-9 Antibody Licensor's Interest: AstraZeneca, through its subsidiary, MedImmune, Inc., is actively developing MEDI-528, a fully humanized monoclonal antibody to interleukin-9 ("IL-9"), as therapy for moderate to severe persistent asthma (collectively "the IL-9 program") and has announced its intention to proceed to a phase 2b trial. The Trust holds the licensor's interest formerly held by Genaera Corporation in the IL-9 antibody program, which includes rights to development and sales milestones and royalties on approved product sales; and
  • Pexiganan Acetate: Pexiganan is a novel, small peptide anti-infective, active against multi-drug resistant bacteria (MRSA, MDRAB), developed in a topical cream form. Pexiganan is the subject of an open IND and a pending New Drug Application ("NDA") for diabetic foot infection. In clinical trials conducted by Genaera, over 1,000 human subjects were exposed to pexiganan without safety concerns, including 418 patients who received pexiganan in two phase 3 clinical trials submitted in a NDA to the U.S. Food and Drug Administration in 1998.

'/>"/>
SOURCE Genaera Liquidating Trust
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Genaera Receives Non-Compliance Notice from Nasdaq
2. Genaera to Present at BIO-Europe 2008
3. Genaera Corporation Announces Second Quarter Financial Results
4. Genaera Corporation Elects Paul K. Wotton to Board of Directors
5. Genaera Corporation to Present at BIO Business Forum
6. Genaera Corporation Announces First Quarter Financial Results
7. Genaera Corporation Announces 2007 Financial Results
8. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
9. Genaera Corporation Announces Third Quarter Financial Results
10. Genaera to Present at Biotech 2007 and BIO InvestorForum
11. Genaera Elects New Board Member and Announces Executive Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... “This kit has an improved extraction efficiency and ... 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for ... owners and USDA-GIPSA inspection agencies that have a need to ... place in a matter of minutes with nothing but our ... feed and grain before accepting it, but they no longer ...
(Date:8/28/2014)... month, executives from clinical trial marketing firm BBK Worldwide will ... Patient-Centered Clinical Trials 2014 , to be held at the ... 4-5. Patient recruitment experts Bonnie A. Brescia , ... insights on the benefits of employing an effective patient engagement ... to mobile apps – can be used to drive study ...
(Date:8/28/2014)... (PRWEB) August 27, 2014 Scientists, researchers, ... for SPIE Laser Damage 2014 symposium. Marking ... for high-power lasers will run 14-17 September. The event ... optics and photonics . , The premier conference for ... laser damage to optical materials will engage researchers and ...
(Date:8/28/2014)... Whitehouse Laboratories is excited to announce ... PTI Inspection Systems that will enable it ... art leak testing method development and validation programs using ... As part of this agreement, Whitehouse Labs has taken ... Instrument developed and manufactured by PTI. The HVLD ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3
... FRANCISCO, Calif., Dec. 8 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... chief executive officer, will participate in a panel,discussion at the ... and Targets for Inflammation and Rheumatology", will take,place on Wednesday, ... Times,Square Hotel in New York City. , ...
... MINNEAPOLIS, Dec. 8 ATS Medical, Inc.,(Nasdaq: ATSI ... today announced it has received FDA clearance for the,marketing of ... tab,material supplier and an improved valve holder accessory device. , ... ) , While the ...
... When it comes to the world of the very, very ... and its capacity to alter the fundamentals of nature, it ... In a report published today (Dec. 7) in the journal ... and Europe reveal a sharp contrast in the perception that ...
Cached Biology Technology:ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 2ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 3For nano, religion in US dictates a wary view 2For nano, religion in US dictates a wary view 3
(Date:8/28/2014)... of new roads will be built worldwide by 2050. ... wildernesses, where they bring an influx of destructive loggers, ... study has created a ,global roadmap, for prioritising road ... competing demands of development and environmental protection. , The ... that natural importance of ecosystems and a ,road-benefits, layer ...
(Date:8/28/2014)... the world to Global Warming, has called for atmospheric ... He says that Carbon Capture, combined with limits on ... global warming getting out of control over the next ... the call during his presentation to the International Carbon ... to discuss Carbon Capture and Storage. , He ...
(Date:8/28/2014)... assigned a number of 435-million-year-old fossils to a ... in shallow marine habitats and were far less ... , Before they sank to the bottom ... some 435 million years ago, these arthropods preyed ... although they were not exactly inconspicuous, possessing a ...
Breaking Biology News(10 mins):Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Global warming pioneer calls for CO2 to be taken from atmosphere and stored underground 2Paleontology: Oldest representative of a weird arthropod group 2
... is poised to become the first example of a ... a major threat to endangered wildlife that authorities are ... found only in Iran, is considered Critically Endangered and ... individuals. The amphibian is being proposed for an Appendix ...
... Boston, Mass. -- A large study from Children,s Hospital Boston ... that samples the entire genome, known as chromosomal microarray analysis, ... related to autism spectrum disorders (ASDs) than standard tests. Publishing ... March 15), the authors urge that CMA become part of ...
... March 10, 2010 Using a novel light activation technique, ... with only a modest ability to fight specific proteins into ... "warhead" molecule capable of inactivating nearby proteins when triggered by ... by providing researchers with a new set of research tools ...
Cached Biology News:Potential CITES trade ban for rare salamander underscores wildlife e-commerce 2A better genetic test for autism 2A better genetic test for autism 3Light activated 'warhead' turns modest molecules into super protein killers 2Light activated 'warhead' turns modest molecules into super protein killers 3
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Anti-Mouse Reticular Fibroblast, Purified (Clone ER-TR7) (rat IgG2a)...
Mouse monoclonal [2Q2147] to Aequorin ( Abpromise for all tested applications)....
Biology Products: